Seoul, South Korea

Chang-Yuil Kang

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 4.6

ph-index = 5

Forward Citations = 134(Granted Patents)


Company Filing History:


Years Active: 1999-2024

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Chang-Yuil Kang: Innovator in Adenoviral Vector Technology

Introduction

Chang-Yuil Kang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of adenoviral vectors. With a total of 10 patents to his name, his work has the potential to impact vaccine development and cancer treatment.

Latest Patents

Among his latest patents is an innovative adenoviral vector that does not include replication competent adenovirus. This invention relates to a recombinant E1/E3/E4-deleted adenoviral vector, which incorporates an antigenic protein and an E4orf6 gene in an E1 gene-deleted region. The vector demonstrates adenovirus productivity, a degree of antigen expression, neutralizing antibody production, and T cell induction ability comparable to control groups. This technology can be effectively utilized as a carrier for various vaccines, including those for diseases and anti-cancer applications. Another notable patent involves a method for preparing antigen-specific cytotoxic T-cells using activated B-cells. This method allows for the preparation of in vitro/ex vivo antigen-specific cytotoxic T-cells, which can be advantageous in treating infectious diseases and cancer.

Career Highlights

Chang-Yuil Kang has worked with notable companies such as LG Chem and Cellid Co., Ltd. His experience in these organizations has contributed to his expertise in biotechnology and patent development.

Collaborations

Some of his coworkers include Hyun-Jeong Ko and Yeon-Jeong Kim, who have collaborated with him on various projects in the field of biotechnology.

Conclusion

Chang-Yuil Kang's innovative work in adenoviral vector technology and his extensive patent portfolio highlight his significant contributions to the field of biotechnology. His inventions have the potential to advance vaccine development and cancer treatment, making him a key figure in this area of research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…